Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Three-dimensional chromatin landscapes in MLLr AML

ABSTRACT: Three-dimensional chromatin landscapes in MLLr AML

PROVIDER: PRJNA1023233 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26260621_1.fastq.gz	Fastqsanger.gz
	SRR26260621_2.fastq.gz	Fastqsanger.gz
	SRR26260622_1.fastq.gz	Fastqsanger.gz
	SRR26260622_2.fastq.gz	Fastqsanger.gz
	SRR26260623_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Three-dimensional chromatin landscapes in MLLr AML [Micro-C]

Project description:Three-dimensional chromatin landscapes in MLLr AML [Micro-C]

| PRJNA1023239 | ENA

Three-dimensional chromatin landscapes in MLLr AML [RNA-Seq]

Project description:Three-dimensional chromatin landscapes in MLLr AML [RNA-Seq]

| PRJNA1023238 | ENA

Three-dimensional chromatin landscapes in MLLr AML [Micro-C]

Project description:Rearrangements of the mixed lineage leukemia (MLLr) gene are frequently associated with both pediatric and adult leukemia. However, the treatment options for these aggressive MLLr leukemias are limited due to the genomic complexity and dynamics of 3D structure in oncogene transcription and leukemia development. Here, we use Micro-C and transcriptome profiling to examine the MLLr-driven aberrant 3D genome architecture in gene-edited MLL-AF9 AML samples with biologically matched healthy donors. Recurrent and MLLr-specific alterations in A/B compartments, topologically associating domains and chromatin loops were identified. RNA sequencing in the same AML samples also revealed extensive and recurrent MLLr-specific promoter–enhancer and promoter–silencer loops. Overall, this study highlights the critical regulatory elements and provides rational and effective targeting strategy in MLLr AML.

2024-02-20 | GSE244471 | GEO

Three-dimensional chromatin landscapes in MLLr AML [RNA-Seq]

2024-02-20 | GSE244470 | GEO

Three-dimensional chromatin landscapes in MLLr AML

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-02-20 | GSE244472 | GEO

Three-dimensional molecular architecture of mouse organogenesis

Project description:Three-dimensional molecular architecture of mouse organogenesis

| PRJNA994551 | ENA

Reprogramming of three-dimensional chromatin architecture drives human dilated cardiomyopathy

Project description:Reprogramming of three-dimensional chromatin architecture drives human dilated cardiomyopathy

| PRJNA694042 | ENA

Three-dimensional chromatin re-organization during muscle stem cell aging

Project description:Three-dimensional chromatin re-organization during muscle stem cell aging

| PRJNA883688 | ENA

Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.

Project description:Differences in three-dimensional (3D) chromatin architecture can influence the integrity of topologically associating domains (TADs) and rewire specific enhancer-promoter interactions, impacting gene expression and leading to human disease. Here we investigate the 3D chromatin architecture in T cell acute lymphoblastic leukemia (T-ALL) by using primary human leukemia specimens and examine the dynamic responses of this architecture to pharmacological agents. Systematic integration of matched in situ Hi-C, RNA-seq and CTCF ChIP-seq datasets revealed widespread differences in intra-TAD chromatin interactions and TAD boundary insulation in T-ALL. Our studies identify and focus on a TAD 'fusion' event associated with absence of CTCF-mediated insulation, enabling direct interactions between the MYC promoter and a distal super-enhancer. Moreover, our data also demonstrate that small-molecule inhibitors targeting either oncogenic signal transduction or epigenetic regulation can alter specific 3D interactions found in leukemia. Overall, our study highlights the impact, complexity and dynamic nature of 3D chromatin architecture in human acute leukemia.

| S-EPMC7138649 | biostudies-literature

Phase 0 study of three-dimensional endoscopic optical coherence tomography (u-VOIS)

Project description:Interventions: Endoscopic examinations of mucosal membrane using three-dimensional optical coherence tomography probe. Primary outcome(s): Discrimination ability of mucosal membrane structure. Discrimination ability of cancer tissue. Study Design: Single arm Non-randomized

| 2618337 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data